SCHEMBL5163780

SCHEMBL5163780

CC(C)(C)OC(=O)N1CCC[C@H](COc2ccc(C(F)(F)F)cc2[N+](=O)[O-])C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.51
MAPT P10636 4/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
LMNA P02545 2/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ALOX5AP P20292 1/20 0.43
FEN1 P39748 1/20 0.43
CHEK2 O96017 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
BTK Q06187 1/20 0.41
BCHE P06276 1/20 0.40
HTR6 P50406 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5166008 1.00 SCN9A (0.51) SCN9AMAPTCYP1A2CYP3A4CYP2D6
SCHEMBL5163789 1.00 SCN9A (0.51) SCN9AMAPTCYP1A2CYP3A4CYP2D6
SCHEMBL27701055 0.88 MAPT (0.48) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL27701054 0.88 MAPT (0.48) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5162273 0.85 SCN9A (0.54) SCN9AMAPTALOX5APFEN1CHEK2
SCHEMBL5163390 0.85 SCN9A (0.54) SCN9AMAPTALOX5APFEN1CHEK2
SCHEMBL5068253 0.85 SCN9A (0.54) SCN9AMAPTALOX5APFEN1CHEK2
SCHEMBL27700848 0.84 MAPT (0.44) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL27681910 0.84 MAPT (0.44) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL27700728 0.84 MAPT (0.44) MAPTCYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765808-A1 BISARYLUREA DERIVATIVES USEFUL FOR INHIBITING CHK1 ICOS Corporation (US) 2007-03-28 EP disclosed
WO-2006012308-A1 BISARYLUREA DERIVATIVES USEFUL FOR INHIBITING CHK1 ICOS CORPORATION (US) 2006-02-02 WO disclosed